Lifecore Biomedical (LFCR)
Develops and manufactures sterile injectable products and pharmaceutical-grade hyaluronic acid.
$4.49
vs last close+0.01 (+0.22%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
−$0.30
Revenue estimate
$25.6M
Fiscal quarter
Q1 FY27
EPSReportedEstimate
Jan '25Apr '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.25−$0.47−$0.10−$0.29−$0.19−$0.43−$0.19Pending
Estimate−$0.27−$0.14−$0.09−$0.30−$0.18−$0.24−$0.19−$0.30
Surprise+7.4%−235.7%−11.1%+3.3%−5.6%−79.2%0.0%—
RevenueReportedEstimate
Jan '25Apr '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$32.6M$35.2M$36.4M$31.1M$34.2M$23.2M$34.2MPending
Estimate$29.7M$33.2M$35.4M$26.3M$35.2M$26.0M$32.0M$25.6M
Surprise+9.5%+5.7%+3.0%+18.5%−2.8%−10.6%+6.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2033 | $0.00 | — | — |
| Sep 2033 | $0.00 | — | — |
| Jun 2033 | $0.00 | — | — |
| Mar 2033 | $0.00 | — | — |
| Dec 2032 | −$0.17 | — | — |
| Sep 2032 | −$0.21 | — | — |
| Jun 2032 | −$0.22 | — | — |
| Mar 2032 | −$0.24 | — | — |
| Dec 2031 | −$0.16 | — | — |
| Sep 2031 | −$0.23 | — | — |
| Jun 2031 | −$0.21 | — | — |
| Mar 2031 | −$0.29 | — | — |
| Dec 2030 | −$0.29 | — | — |
| Sep 2030 | −$0.10 | — | — |
| Jun 2030 | −$0.15 | — | — |
| Mar 2030 | −$0.29 | — | — |
| Dec 2029 | −$0.49 | — | — |
| Sep 2029 | −$0.12 | — | — |
| Jun 2029 | −$0.06 | — | — |
| Mar 2029 | −$0.21 | — | — |
| Dec 2028 | −$0.39 | — | — |
| Sep 2028 | −$0.45 | — | — |
| Jun 2028 | −$0.19 | — | — |
| Mar 2028 | −$0.25 | — | — |
| Dec 2027 | −$0.21 | — | — |
| Sep 2027 | −$0.28 | — | — |
| Jun 2027 | −$0.10 | — | — |
| Mar 2027 | −$0.30 | — | — |
| Dec 2026 | −$0.19 | — | — |
| Nov 2026 | −$0.30 | — | — |
| Aug 2026 | −$0.19 | −$0.19 | 0.0% |
| Mar 2026 | −$0.18 | −$0.19 | −5.6% |
| May 2026 | −$0.24 | −$0.43 | −79.2% |
| Nov 2025 | −$0.30 | −$0.29 | +3.3% |
| Aug 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Aug 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| Apr 2022 | |||
| Jan 2022 | |||
| Sep 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Jan 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| Mar 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Sep 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Sep 2016 | |||
| Jul 2016 | |||
| Mar 2016 | |||
| Jan 2016 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2033 | $0.00 | — | — | $44.5M | — | — | — |
| Sep 2033 | $0.00 | — | — | $40.1M | — | — | — |
| Jun 2033 | $0.00 | — | — | $36.3M | — | — | — |
| Mar 2033 | $0.00 | — | — | $35.1M | — | — | — |
| Dec 2032 | −$0.17 | — | — | $40.0M | — | — | — |
| Sep 2032 | −$0.21 | — | — | $34.3M | — | — | — |
| Jun 2032 | −$0.22 | — | — | $31.2M | — | — | — |
| Mar 2032 | −$0.24 | — | — | $30.0M | — | — | — |
| Dec 2031 | −$0.16 | — | — | $35.9M | — | — | — |
| Sep 2031 | −$0.23 | — | — | $31.6M | — | — | — |
| Jun 2031 | −$0.21 | — | — | $29.8M | — | — | — |
| Mar 2031 | −$0.29 | — | — | $26.8M | — | — | — |
| Dec 2030 | −$0.29 | — | — | $33.1M | — | — | — |
| Sep 2030 | −$0.10 | — | — | $35.4M | — | — | — |
| Jun 2030 | −$0.15 | — | — | $33.2M | — | — | — |
| Mar 2030 | −$0.29 | — | — | $29.7M | — | — | — |
| Dec 2029 | −$0.49 | — | — | $23.2M | — | — | — |
| Sep 2029 | −$0.12 | — | — | $35.0M | — | — | — |
| Jun 2029 | −$0.06 | — | — | $42.8M | — | — | — |
| Mar 2029 | −$0.21 | — | — | $36.2M | — | — | — |
| Dec 2028 | −$0.39 | — | — | $40.0M | — | — | — |
| Sep 2028 | −$0.45 | — | — | $30.9M | — | — | — |
| Jun 2028 | −$0.19 | — | — | $38.0M | — | — | — |
| Mar 2028 | −$0.25 | — | — | $30.8M | — | — | — |
| Dec 2027 | −$0.21 | — | — | $34.8M | — | — | — |
| Sep 2027 | −$0.28 | — | — | $27.0M | — | — | — |
| Jun 2027 | −$0.10 | — | — | $38.6M | — | — | — |
| Mar 2027 | −$0.30 | — | — | $25.6M | — | — | — |
| Dec 2026 | −$0.19 | — | — | $34.2M | — | — | — |
| Nov 3, 2026 | −$0.30 | — | — | $25.6M | — | — | — |
| Aug 5, 2026 | −$0.19 | −$0.19 | 0.0% | $32.0M | $34.2M | +6.7% | +2.1% |
| Mar 9, 2026 | −$0.18 | −$0.19 | −5.6% | $35.2M | $34.2M | −2.8% | +0.3% |
| May 6, 2026 | −$0.24 | −$0.43 | −79.2% | $26.0M | $23.2M | −10.6% | −3.9% |
| Nov 6, 2025 | −$0.30 | −$0.29 | +3.3% | $26.3M | $31.1M | +18.5% | +3.5% |
| Aug 7, 2025 | |||||||
| Apr 3, 2025 | |||||||
| Jan 2, 2025 | |||||||
| Oct 4, 2024 | |||||||
| Aug 26, 2024 | |||||||
| May 22, 2024 | |||||||
| Mar 21, 2024 | |||||||
| Nov 30, 2023 | |||||||
| Aug 31, 2023 | |||||||
| Aug 23, 2023 | |||||||
| Jun 1, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Oct 6, 2022 | |||||||
| Aug 10, 2022 | |||||||
| Apr 5, 2022 | |||||||
| Jan 5, 2022 | |||||||
| Sep 29, 2021 | |||||||
| Jul 28, 2021 | |||||||
| Apr 7, 2021 | |||||||
| Jan 6, 2021 | |||||||
| Oct 6, 2020 | |||||||
| Aug 11, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Jan 2, 2020 | |||||||
| Oct 1, 2019 | |||||||
| Jul 30, 2019 | |||||||
| Apr 3, 2019 | |||||||
| Jan 3, 2019 | |||||||
| Oct 2, 2018 | |||||||
| Jul 31, 2018 | |||||||
| Apr 3, 2018 | |||||||
| Jan 3, 2018 | |||||||
| Sep 26, 2017 | |||||||
| Jul 25, 2017 | |||||||
| Apr 4, 2017 | |||||||
| Jan 4, 2017 | |||||||
| Sep 27, 2016 | |||||||
| Jul 26, 2016 | |||||||
| Mar 29, 2016 | |||||||
| Jan 5, 2016 | |||||||
| Sep 29, 2015 |